(Q39071340)

8 September 2017

title

Lipid Synthesis Is a Metabolic Liability of Non-Small Cell Lung Cancer (English)

1 reference

8 September 2017

1 reference

Robert U Svensson

1

1 reference

8 September 2017

Reuben J Shaw

series ordinal

2

1 reference

8 September 2017

publication date

6 January 2017

1 reference

Cold Spring Harbor Symposia on Quantitative Biology

8 September 2017

published in

1 reference

8 September 2017

volume

81

1 reference

8 September 2017

page(s)

93-103

1 reference

Regulating the regulator: post-translational modification of RAS

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2(+) Breast Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

ROS-mediated p53 induction of Lpin1 regulates fatty acid oxidation in response to nutritional stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

ATP citrate lyase is an important component of cell growth and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Diacylglycerol Metabolism and Signaling Is a Driving Force Underlying FASN Inhibitor Sensitivity in Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

RNA interference-mediated silencing of the acetyl-CoA-carboxylase-alpha gene induces growth inhibition and apoptosis of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Cancer metabolism: fatty acid oxidation in the limelight

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Targeted therapy with fatty acid synthase inhibitors in a human prostate carcinoma LNCaP/tk-luc-bearing animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Crystal structure of the biotin carboxylase domain of human acetyl-CoA carboxylase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Genetic inhibition of hepatic acetyl-CoA carboxylase activity increases liver fat and alters global protein acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Acetate dependence of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Acidosis Drives the Reprogramming of Fatty Acid Metabolism in Cancer Cells through Changes in Mitochondrial and Histone Acetylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Activation of a metabolic gene regulatory network downstream of mTOR complex 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Acetyl-CoA carboxylase regulates global histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-kinase (PI3K)/AKT pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

ATP citrate lyase inhibition can suppress tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Analysis of p53 transactivation domain mutants reveals Acad11 as a metabolic target important for p53 pro-survival function

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Regulation of mammalian acetyl-coenzyme A carboxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Fatty acid synthesis: a potential selective target for antineoplastic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Loss of regulation of lipogenesis in the Zucker diabetic (ZDF) rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Acetate fuels the cancer engine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Acetate is a bioenergetic substrate for human glioblastoma and brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

The multifaceted roles of fatty acid synthesis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

The LKB1-AMPK pathway: metabolism and growth control in tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

A mechanism for the potent inhibition of eukaryotic acetyl-coenzyme A carboxylase by soraphen A, a macrocyclic polyketide natural product.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

AMPK in Health and Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Increased lipogenesis in cancer cells: new players, novel targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Lipogenetic and glycolytic enzyme activities in carcinoma and nonmalignant diseases of the human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Acetyl-coenzyme A carboxylases: versatile targets for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Fatty acid metabolism: target for metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

The relationship of thioredoxin-1 and cisplatin resistance: its impact on ROS and oxidative metabolism in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

ATP-citrate lyase links cellular metabolism to histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Cytosolic acetyl-CoA synthetase affected tumor cell survival under hypoxia: the possible function in tumor acetyl-CoA/acetate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2016.81.030874

10.1101/SQB.2016.81.030874

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference